Interphenylene 7-oxabicyclic(2.2.1)heptane oxazoles as prostaglandin F2a antagonists

Details for Australian Patent Application No. 2001292595 (hide)

Owner Allergan, Inc.

Inventors Burk, Robert M; Garst, Michael E.; Donde, Yariv

Agent Davies Collison Cave

Pub. Number AU-B-2001292595

PCT Pub. Number WO02/22621

Priority 09/661,771 14.09.00 US

Filing date 7 September 2001

Wipo publication date 26 March 2002

Acceptance publication date 17 August 2006

International Classifications

C07D 493/08 (2006.01) Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system

Event Publications

17 August 2006 Application Accepted

  Published as AU-B-2001292595

14 December 2006 Standard Patent Sealed

1 May 2008 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2001292596-Electro-explosive device with laminate bridge

2001292594